Inventor · disambiguated record
Matthew Stubbs
Also filed as: STUBBS MATTHEW · STUBBS MATTHEW C
3 granted patents·1 pending application·2 citations·filing 2020–2023
53Inventor score
Technology areasA61K
Files withINCYTE CORP4
Top patents by PatentIndex Score
4 records- 0188US11833155B2Combination therapy for treatment of myeloproliferative neoplasmsINCYTE CORP·Filed 2021·Granted Dec 5, 2023·2 cites·27 claims
- 0270US12440495B2Combination therapy for treatment of myeloproliferative neoplasmsINCYTE CORP·Filed 2023·Granted Oct 14, 2025·0 cites·26 claims
- 0366US2024041887A1Combination therapy comprising an alk2 inhibitor and a jak2 inhibitorINCYTE CORP·Filed 2023·Application pending·0 cites
- 0460US11738026B2Combination therapy comprising an ALK2 inhibitor and a JAK2 inhibitorINCYTE CORP·Filed 2020·Granted Aug 29, 2023·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when Matthew Stubbs files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →